Case details

Print
Merger control
Case reference
CCENT/2007/53 - KYPHON, INC./MEDTRONIC, INC.
Acquired
Kyphon
Description
Kyphon is a US corporation quoted on the stock exchange (NASDAQ), with its headquarters in California. Kyphon is a global medical device company that specialises in the design, manufacture and marketing of medical devices for the treatment and restoration of the anatomy of the spinal column, the diagnoses of vertebral disc disorders and maintenance of spinal column mobility, and the diagnosis of causes of lumbar pain, using minimally invasive technology. In Portugal, its activities are limited to the treatment of spinal column fractures.
Acquiring
Medtronic Inc
Description
A US corporation, quoted on the New York Stock Exchange, with its head office in Minnesota. Medtronic operates worldwide, carrying out activities in the field of medical technology: it provides products, therapies and services for the treatment of diabetes and neurological and spinal column diseases. Its main business areas are: treatment of the whole spectrum of heart rhythm diseases; neurological, spinal column and ENT surgery; and the vascular area. In Portugal, Medtronic supplies a wide range of products, therapies and services related to the above areas.
Sector
  • Supply and Food Industry
Activity (NACE)
  • G46 - Wholesale trade (include commission trade), except of motor vehicles and motorcycles
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Horizontal
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
Notified on 7 August 2007, with effect on 11 September 2007, this merger consists of the projected acquisition of exclusive control of KYPHON, INC. (Kyphon) by MEDTRONIC, INC. (Medtronic).
Timeline
Click here to see your activities